Abstract

Carbonic anhydrase 9 (CA9), as one of the most hypoxia-responsive genes, has been associated almost exclusively with hypoxic tumors. Its principal role is in pH regulation which helps tumor cells overcome intracellular acidosis and survive extended periods of time with low oxygen. Hypoxia-inducible factor 1 (HIF-1) is the main transcriptional activator of CA9. Hepatitis B virus X protein (HBx) has been shown to increase the transcriptional activity of HIF-1. HBx is often expressed from the gene integrated in the hepatocytes infected persistently and contributes significantly to alterations in host gene expression that can lead to the development of hepatocellular carcinoma (HCC) associated with Hepatitis B virus (HBV). The aim of this study was to determine the effect of HBx on expression of CA9. Transient transfection of HBx led to an increase in the expression of CA9 as assessed by RT-PCR and Western blotting. HBx was able to increase CA9 promoter activity significantly in several cell lines. The effect was mediated via HIF-1 and a functional HRE element located -10/-3 bp upstream of the CA9 transcription initiation site. These data suggest that CA9 may be involved in the development of HCC by contributing to the survival of hepatocytes infected with HBV in liver tissue with fibrosis.

Highlights

  • Hepatitis B virus (HBV) infection is one of the most common viral infections

  • VEGF and Carbonic anhydrase 9 (CA9) are both hypoxia-regulated genes, and their main transcriptional activator Hypoxia-inducible factor 1 (HIF-1) has been reported to be influenced by HBx

  • It has a role in hepatocarcinogenesis because hepatocellular carcinoma (HCC) incidence has been reported in animals infected with mammalian hepadnaviruses that have a conserved X-open reading frame in their genomes but not in birds infected with avian hepadnaviruses where the X-ORF is absent [Tang et r

Read more

Summary

Introduction

Hepatitis B virus (HBV) infection is one of the most common viral infections. It is selflimiting in 90-95% of adults infected acutely, while the majority of neonatal infections become persistent. Horizontal transmission to children or immunocompromised adults will result in a significant risk of developing persistent infection. Over 350 million people worldwide are infected chronically with HBV, with one million deaths per annum resulting from the complications of chronic infection [Ganem and Prince, 2004; Guidotti and Chisari, 2006]. R. HBV is an enveloped hepatotropic virus. It is a noncytopathic virus and most of the liver damage occurs as a result of immune responses, especially the cytotoxic T lymphocyte (CTL)

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call